IL109613A - Inclusion complexes of taxol or taxotere or taxus extract formed with cyclodextrins, their preparation and use - Google Patents

Inclusion complexes of taxol or taxotere or taxus extract formed with cyclodextrins, their preparation and use

Info

Publication number
IL109613A
IL109613A IL109613A IL10961394A IL109613A IL 109613 A IL109613 A IL 109613A IL 109613 A IL109613 A IL 109613A IL 10961394 A IL10961394 A IL 10961394A IL 109613 A IL109613 A IL 109613A
Authority
IL
Israel
Prior art keywords
taxotere
taxol
preparation
cyclodextrins
inclusion complexes
Prior art date
Application number
IL109613A
Other languages
English (en)
Other versions
IL109613A0 (en
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of IL109613A0 publication Critical patent/IL109613A0/xx
Publication of IL109613A publication Critical patent/IL109613A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nanotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Epoxy Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL109613A 1993-05-12 1994-05-10 Inclusion complexes of taxol or taxotere or taxus extract formed with cyclodextrins, their preparation and use IL109613A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9301373A HU213200B (en) 1993-05-12 1993-05-12 The cyclodextrin or cyclodextrin derivative cluster complexes of taxol, taxotere, or taxus, pharmaceutical preparations containing them and process for their production

Publications (2)

Publication Number Publication Date
IL109613A0 IL109613A0 (en) 1994-08-26
IL109613A true IL109613A (en) 1997-09-30

Family

ID=10983581

Family Applications (1)

Application Number Title Priority Date Filing Date
IL109613A IL109613A (en) 1993-05-12 1994-05-10 Inclusion complexes of taxol or taxotere or taxus extract formed with cyclodextrins, their preparation and use

Country Status (23)

Country Link
US (1) US6284746B1 (de)
EP (1) EP0698018B1 (de)
JP (1) JP3693341B2 (de)
CN (1) CN1123030A (de)
AT (1) ATE225340T1 (de)
AU (1) AU693101B2 (de)
BG (1) BG100207A (de)
BR (1) BR9406292A (de)
CA (1) CA2162716C (de)
CZ (1) CZ291495A3 (de)
DE (1) DE69431476T2 (de)
DK (1) DK0698018T3 (de)
ES (1) ES2184764T3 (de)
FI (1) FI955424A0 (de)
HU (1) HU213200B (de)
IL (1) IL109613A (de)
NO (1) NO954545L (de)
OA (1) OA10323A (de)
PL (1) PL311561A1 (de)
PT (1) PT698018E (de)
SK (1) SK140595A3 (de)
WO (1) WO1994026728A1 (de)
YU (1) YU26894A (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2880292B2 (ja) 1992-11-27 1999-04-05 ナプロ バイオセラピューティクス，インコーポレイテッド 注射可能組成物
US5716981A (en) * 1993-07-19 1998-02-10 Angiogenesis Technologies, Inc. Anti-angiogenic compositions and methods of use
HUT73844A (en) * 1994-11-11 1996-09-30 Chinoin Gyogyszer Es Vegyeszet New taxol complexes and pharmaceutical compositions containing them
HUP9701945A3 (en) * 1997-11-10 2000-04-28 Hexal Ag Pharmaceutical composition for injection containing cyclodextrin and taxoids
DK1052974T3 (da) * 1998-02-05 2009-08-10 Novartis Ag Farmaceutisk sammensætning indeholdende epothilon
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
TWI321054B (en) * 2000-12-19 2010-03-01 California Inst Of Techn Compositions containing inclusion complexes
GB0127677D0 (en) * 2001-11-19 2002-01-09 Vianex S A Inclusion complex
US20040106199A1 (en) * 2002-12-02 2004-06-03 Eliseev Alexey V. Charged cyclodextrin derivatives and their use in plant cell and tissue culture growth media
CN100411688C (zh) * 2006-09-12 2008-08-20 南京师范大学 含有环糊精/多烯紫杉醇包合物的药物组合物及其制备方法
CN100486645C (zh) * 2006-09-12 2009-05-13 南京师范大学 含有环糊精紫杉醇包合物的药物组合物及其制备方法
CN101278929B (zh) * 2007-04-02 2011-05-18 王效山 含有藤黄酸类化合物的药物及藤黄酸类化合物的包合物的制备方法
ES2310122B1 (es) * 2007-04-20 2009-10-30 Instituto Cientifico Y Tecnologico De Navarra, S.A Nanoparticulas que comprenden una ciclodextrina y una molecula biologicamente activa y sus aplicaciones.
ITMI20071321A1 (it) * 2007-07-04 2009-01-05 Sea Marconi Technologies Di Va Nanospugne a base di ciclodestrine come veicolo per farmaci antitumorali
CL2007003876A1 (es) * 2007-12-28 2008-03-07 Univ De Concepcion Y Lab Andro Complejo de inclusion que esta formado por disulfiram y ciclodextrina; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de la dependencia de alcohol y cocaina.
US9492417B2 (en) 2008-08-21 2016-11-15 The Johns Hopkins University Methods and compositions for administration of 3-halopyruvate and related compounds for the treatment of cancer
WO2015108932A1 (en) * 2014-01-14 2015-07-23 The Johns Hopkins University Liposome compositions encapsulating modified cyclodextrin complexes and uses thereof
CN103920163B (zh) * 2014-03-14 2016-09-14 南京大学 一种紫杉醇复合物、制备方法及其应用
EP3370712B1 (de) 2015-11-06 2025-02-19 The Johns Hopkins University 3-brompyruvat zur behandlung von leberfibrose
GB201715008D0 (en) * 2017-09-18 2017-11-01 Inst De Medicina Molecular Faculdade De Medicina Univ De Lisboa TRPV2 Antagonists
US12414914B2 (en) 2018-07-25 2025-09-16 Bika Biotechnology (Guangzhou) Co., Ltd Docetaxel composition for injection and preparation method therefor

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU181703B (en) * 1980-05-09 1983-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents
HU191101B (en) * 1983-02-14 1987-01-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu Process for preparing water-soluble cyclodextrin polymers substituted with ionic groups
JPS62120324A (ja) * 1985-11-20 1987-06-01 Nippon Junyaku Kk 有機物質の水溶化方法
JP2651567B2 (ja) * 1986-03-20 1997-09-10 花王株式会社 メチル化β−シクロデキストリン
IE62095B1 (en) * 1988-03-29 1994-12-14 Univ Florida Pharmaceutical formulations for parenteral use
JP2929108B2 (ja) * 1988-10-28 1999-08-03 株式会社資生堂 化粧料および粉末化粧料
IT1227626B (it) 1988-11-28 1991-04-23 Vectorpharma Int Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
JPH02200671A (ja) * 1989-01-30 1990-08-08 Agency Of Ind Science & Technol インドールを抽出分離する方法およびインドール包接分離用薬剤
JPH035438A (ja) * 1989-05-31 1991-01-11 Kaken Pharmaceut Co Ltd フルルビプロフェン包接化合物およびこの包接化合物を用いる消炎鎮痛剤
GB8920135D0 (en) * 1989-09-06 1989-10-18 Erba Carlo Spa Use of dehydrated cyclodextrins for improving drug dissolution
KR0166088B1 (ko) * 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
HU211648A9 (en) 1990-03-28 1995-12-28 Chinoin Gyogyszer Es Vegyeszet Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same
EP0485614B1 (de) * 1990-05-21 1997-08-13 Toppan Printing Co., Ltd. Cyclodextrinderivat
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
US5278324A (en) * 1990-08-28 1994-01-11 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
JPH0753396A (ja) 1993-08-19 1995-02-28 Ensuiko Sugar Refining Co Ltd タキソールのサイクロデキストリン包接物，その製造法および用途
JPH06157330A (ja) * 1992-11-27 1994-06-03 Ensuiko Sugar Refining Co Ltd タキソールのサイクロデキストリン包接物，その製造法と用途
US5439686A (en) * 1993-02-22 1995-08-08 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor

Also Published As

Publication number Publication date
EP0698018B1 (de) 2002-10-02
NO954545D0 (no) 1995-11-10
SK140595A3 (en) 1996-10-02
ES2184764T3 (es) 2003-04-16
NO954545L (no) 1995-11-10
DE69431476D1 (de) 2002-11-07
PT698018E (pt) 2003-02-28
AU7008194A (en) 1994-12-12
DK0698018T3 (da) 2003-02-10
WO1994026728A1 (en) 1994-11-24
HU9301373D0 (en) 1993-09-28
HU213200B (en) 1997-03-28
ATE225340T1 (de) 2002-10-15
DE69431476T2 (de) 2003-06-18
AU693101B2 (en) 1998-06-25
BR9406292A (pt) 1995-12-26
YU26894A (sh) 1997-05-28
JP3693341B2 (ja) 2005-09-07
FI955424L (fi) 1995-11-10
EP0698018A1 (de) 1996-02-28
IL109613A0 (en) 1994-08-26
FI955424A7 (fi) 1995-11-10
BG100207A (bg) 1996-05-31
FI955424A0 (fi) 1995-11-10
CA2162716C (en) 2005-03-08
OA10323A (en) 1997-10-07
JPH08510232A (ja) 1996-10-29
HUT68589A (en) 1995-06-28
CN1123030A (zh) 1996-05-22
US6284746B1 (en) 2001-09-04
PL311561A1 (en) 1996-02-19
CZ291495A3 (en) 1996-04-17
CA2162716A1 (en) 1994-11-24

Similar Documents

Publication Publication Date Title
IL109613A0 (en) Inclusion complexes of taxol or taxotere or taxus extract formed with cyclodextrins, their preparation and use
MX9306924A (es) Composiciones antitumorales que contienen derivados de taxano.
ATE152910T1 (de) Verwendung von taxol zur herstellung eines arzneimittels zur behandlung von krebs
DE69703294D1 (de) Zusammensetzungen die konjugate von cis-docosahexaenoic-säure und taxotere enthalten
EA200000282A1 (ru) Способ введения таксана пациенту, нуждающемуся в лечении таксаном, способ лечения человека таксаном (варианты)
WO1994011010A3 (en) Compositions of oak bark extract, related synthetic compositions, and method of using same
NO964433D0 (no) Farmasöytiske preparater på basis av derivater av taxanklassen
JO1696B1 (en) Acetamide derivatives
ATE219061T1 (de) Huperzin a analoge verbindungen
HUT51594A (en) Process for production of celates and their complexes containing ortolizating functional groups, compositions containing such active substances and process for production of conjugates consisting of one complex and linked to it antibody or fragment of antibody
ATE305791T1 (de) Pharmazeutische zubereitungen zur behandlung von magengeschwüren
AU5170499A (en) Use of ginkgo biloba extracts for preparing a medicine for treating amyotrophic lateral sclerosis
DK0865738T3 (da) Oplöseligt natamycin-proteinkompleks
DE69815100D1 (de) Zusammensetzungen, die dolastatin-15-analoge in kombination mit taxane und dessen derivaten enthalten
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
AU5848690A (en) Preparation for topical treatment of infections caused by virus, bacteria and fungi
DE59305285D1 (de) Transdermales therapeutisches system mit pentylentetrazol als wirkstoff
ES2113647T3 (es) Composicion.
IL109049A0 (en) Taxanes having a pyridyl substituted side-chain and pharmaceutical compositions containing them
WO2003013498A3 (de) Nitratester-cyclodextrinkomplexe zur behandlung von erkrankungen insbesondere koronarerkrankungen
UA15363A (uk) Засіб для лікуваhhя відкритих пошкоджеhь
UA18224A (uk) Спосіб лікуваhhя дерматозів
UA32350A (uk) Спосіб лікування гострого інфаркту міокарда
IT1274356B (it) Tassani semisintetici odtati di attivita' antitumorale
IT1278108B1 (it) Secotassani dotati di attivita' antitumorale.

Legal Events

Date Code Title Description
FF Patent granted
RH Patent void